Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Investor Presentation
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
ASX Announcements
Filter by Year:
2020
2019
2018
30-Aug-2019
Results of Annual General Meeting
21-Aug-2019
Change of Director's Interest - S Wilkinson - Options Lapsed
12-Aug-2019
Amplia Therapeutics - Quarterly Update
5-Aug-2019
Change of Director's Interest - Dr Warwick Tong Rights Issue
5-Aug-2019
Change of Director's Interest - Dr Chris Burns, Rights Issue
5-Aug-2019
Change of Director's Interest - Andrew Cooke, Rights Issue
31-Jul-2019
Appendix 4C - Quarterly Cash Flow Report - June 2019 Qtr
31-Jul-2019
RightsIssue Participation Supports Clinical-Enabling Studies
25-Jul-2019
Amplia Therapeutics - Bioshares Presentation July 2019
25-Jul-2019
Appendix 4G - Key to Corporate Governance Disclosures
Previous
1
2
3
4
Next
